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Abstract
In the present study, we explore the role of apoptosis signal-regulating kinase 1 (ASK1) in
denbinobin-induced apoptosis in human lung adenocarcinoma (A549) cells. Denbinobin-induced
cell apoptosis was attenuated by an ASK1 dominant-negative mutant (ASK1DN), two antioxidants
(N-acetyl-L-cysteine (NAC) and glutathione (GSH)), a c-Jun N-terminal kinase (JNK) inhibitor
(SP600125), and an activator protein-1 (AP-1) inhibitor (curcumin). Treatment of A549 cells with
denbinobin caused increases in ASK1 activity and reactive oxygen species (ROS) production, and
these effects were inhibited by NAC and GSH. Stimulation of A549 cells with denbinobin caused
JNK activation; this effect was markedly inhibited by NAC, GSH, and ASK1DN. Denbinobin
induced c-Jun phosphorylation, the formation of an AP-1-specific DNA-protein complex, and Bim
expression. Bim knockdown using a bim short interfering RNA strategy also reduced denbinobin-
induced A549 cell apoptosis. The denbinobin-mediated increases in c-Jun phosphorylation and Bim
expression were inhibited by NAC, GSH, SP600125, ASK1DN, JNK1DN, and JNK2DN. These
results suggest that denbinobin might activate ASK1 through ROS production to cause JNK/AP-1
activation, which in turn induces Bim expression, and ultimately results in A549 cell apoptosis.
Background
Denbinobin (5-hydroxy-3,7-dimethoxy-1,4-phenan-
thraquinone) is purified from several Dendrobium  or
Ephemerantha (Orchidaceae) species, such as D. nobile [1],
D. moniliforme [2], and E. lonchophylla [3,4]. It has been
shown that denbinobin possesses many biological effects
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such as antioxidation, antiplatelet aggregation, and anti-
inflammation. It was also demonstrated to induce cell
death in colon adenocarcinoma (COLO 205) cells, ovary
adenocarcinoma (SK-OV-3) cells, human leukemia
(K562) cells, promyelocytic leukemia (HL60) cells, and
human lung adenocarcinoma (A549) cells [1,5-7]. Previ-
ous studies demonstrated that alterations in tubulin
polymerization and Bcr-Abl activity are involved in den-
binobin-induced human K562 leukemia cell death [5].
Recently, we demonstrated that Akt inactivation, followed
by Bad activation, mitochondrial dysfunction, the release
of mitochondrial molecules such as cytochrome c, second
mitochondria-derived activator of caspase (Smac), and
apoptosis-inducing factor (AIF), and caspase 3 activation
contributes to denbinobin-induced A549 cell apoptosis
[6]. However, the precise molecular mechanism of den-
binobin-induced A549 cell apoptosis has not been fully
delineated.
Apoptosis signal-regulating kinase 1 (ASK1) is a multi-
functional serine/threonine protein kinase that partici-
pates in diverse physiological processes, including cell
differentiation and apoptosis [8,9]. ASK1 has been
reported to be activated by many stress signals, including
H2O2, tumor necrosis factor (TNF)-, and endoplasmic
reticular stress [10-12]. However, the role of ASK1 in den-
binobin-induced A549 cell apoptosis is still unknown.
Bim is a member of the "BH3-only proteins", a subgroup
of Bcl-2 apoptotic regulators which contain only one of
the bcl-2 homologous regions (BH3). In response to
apoptotic stimuli, BH3-only proteins are translocated to
mitochondrial membranes from other cellular compart-
ments where they interfere with the function of antiapop-
totic Bcl-2 family members, leading to apoptotic cell
death [13,14].
In the present study, we explored the roles of ASK1 in den-
binobin-induced cell death in human lung adenocarci-
noma (A549) cells. Our data demonstrate for the first
time that denbinobin might activate ASK1 through reac-
tive oxygen species (ROS) production to cause JNK/AP-1
activation, which in turn induces Bim expression, and
ultimately results in A549 cell apoptosis.
Materials and methods
Materials
Denbinobin was kindly provided by Dr. Chien-Chih
Chen (National Research Institute of Chinese Medicine,
Taipei, Taiwan). The methods of extraction and isolation
of denbinobin were previously reported [3], and the
purity exceeded 98% based on a high-performance liquid
chromatographic (HPLC) analysis. Dulbecco's modified
Eagle's medium (DMEM)/Ham's F-12, fetal calf serum
(FCS), penicillin/streptomycin, OptiMEM, Lipofectamine
plus™ reagent, and TRIzol reagent were purchased from
Invitrogen (Carlsbad, CA). Antibodies specific for phos-
pho-JNK1/2 (Thr183/Tyr185), JNK1/2, and phospho-Akt
(Ser473) were purchased from New England Biolabs (Bev-
erly, MA). The -tubulin antibody was purchased from
Novus Biologicals (Littleton, CO). Protein A/G beads,
antibodies specific for JNK1, phospho-c-Jun, c-Jun, c-Fos,
Akt1/2, and GAPDH, as well as horseradish peroxidase-
conjugated anti-mouse and anti-rabbit antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-mouse immunoglobulin G (IgG)-conjugated
alkaline phosphatase was purchased from Jackson
Immuno Research Laboratories (West Grove, PA). The
enhanced chemiluminescence detection agent was pur-
chased from PerkinElmer Life Sciences (Boston, MA). 4-
Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-
indolyl-phosphate (BCIP) were purchased from Boe-
hringer Mannheim (Mannheim, Germany). All materials
for sodium dodecylsulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) were obtained from Bio-Rad (Her-
cules, CA). SP600125 was purchased from Calbiochem-
Novabiochem (San Diego, CA). 2',7'-Dichlorodihydroflu-
orescein diacetate (H2DCFDA) was purchased from
Molecular Probes (Eugene, OR). ASK1DN, JNK1DN, and
JNK2DN were kindly provided by Dr. Mei-Chieh Chen
(Taipei Medical University, Taipei, Taiwan). All materials
for agarose gel electrophoresis and [-32P] ATP were
obtained from GE Healthcare (Little Chalfont, UK). The
RNAi-Ready pSIREN-RetroQ-ZsGreen vector was pur-
chased from BD Biosciences-Clontech (Palo Alto, CA). All
materials for sqRT-PCR were obtained from Protech Tech-
nology (Taipei, Taiwan). N-Acetyl-L-cysteine (NAC), glu-
tathione (GSH), propidium iodide (PI), dithiothreitol
(DTT), phenylmethylsulphonyl fluoride (PMSF), pepsta-
tin A, leupeptin, SDS, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyltetrazolium (MTT), and other chemicals were
obtained from Sigma (St. Louis, MO).
Cell culture
A549 cells, a human pulmonary type II epithelial adeno-
carcinoma cell line, were obtained from the American
Type Culture Collection and cultured in DMEM/Ham's F-
12 nutrient mixture with 10% FCS and antibiotics (100
U/ml penicillin and 100 g/ml streptomycin). Cells were
cultured at 37°C in a humidified 5% CO2 atmosphere.
Flow cytometric analysis
A549 cells were cultured in 10-cm Petri dishes. After
reaching confluence, cells were transfected with different
plasmid DNAs for 6 h or pretreated with specific inhibi-
tors for 30 min as indicated followed by treatment with 20
M denbinobin for additional 24 h. After treatment, cells
were harvested and washed twice with phosphate-buff-
ered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, and 1.5 mM KH2PO4; pH 7.4), and re-sus-
pended in ice-cold 70% ethanol at -20°C overnight. CellsJournal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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were washed for 5 min with 0.4 ml phosphate-citric acid
buffer (pH 7.8) containing 50 mM Na2HPO4, 25 mM cit-
ric acid, and 0.1% Triton X-100 and subsequently stained
with 1.5 ml PI staining buffer containing 0.5% Triton X-
100, 10 mM PIPES, 100 mM NaCl, 2 mM MgCl2, 0.1 U/
ml RNase A, and 25 g/ml PI for 30 min in the dark before
the flow cytometric analysis. Samples were analyzed by
FACScan and the Cellquest program (Becton Dickinson,
San Jose, CA).
Cell viability assay
Cell viability was measured by a previously described
colorimetric MTT assay [15]. Briefly, cells (2 × 105 cells/
well) were cultured in 24-well plates and transfected with
different plasmid DNAs for 6 h or pretreated with specific
inhibitors for 30 min as indicated followed by incubation
with 20 M denbinobin for another 24 h. After various
treatments, 1 mg/ml MTT was added to the culture plates
and incubated at 37°C for an additional 4 h. Then cells
were lysed in 500 l dimethyl sulfoxide. The absorbance
at 550 nm was measured on a microplate reader. Each
experiment was performed in triplicate and repeated at
least three times.
Plasmid DNA transfection
A549 cells were seeded at a density of 2 × 105 cells/ml into
12-well plates. Cells were transfected on the following day
with the Lipofectamine plus™ reagent containing 1 g/
well of pcDNA (mock), ASK1DN, JNK1DN, JNK2DN, pSi-
REN-NC, or pSiREN-bim cDNA in Opti-MEM for 6 h. At
the end of transfection, the medium was aspirated and
replaced with fresh culture medium for 24 h. Cells were
treated with 20 M denbinobin for various time periods
dependent on different experiments before harvesting. To
determine the transfection efficiency, cells were trans-
fected with 1 g of pEGFP, a green fluorescence protein
(GFP) expression vector for 24 h. After treatment, the
medium was aspirated and replaced with fresh DMEM/
Ham's F12 containing 10% FBS for another 24 h. Cells
were observed under inverted laser scanning confocal
microscopy (Olympus). The transfection efficacy was
defined as the percentage of cells expressing GFP. The
transfection rate of GFP was about 33% (data not shown).
Measurements of ASK1 and JNK kinase activity
A549 cells were seeded in 6-cm dishes. After reaching con-
fluence, cells were treated with 20 M denbinobin for 10,
30, 60, or 120 min. After treatment, cells were lysed with
lysis buffer containing 20 mM Tris-HCl (pH 7.5), 1 mM
MgCl2, 125 mM NaCl, 1% Triton X-100, 1 mM PMSF, 10
g/ml leupeptin, 10 g/ml aprotinin, 25 mM -glycero-
phosphate, 50 mM NaF, and 100 M Na3VO4, and centri-
fuged at 4°C and 12,000 × g for 30 min. The supernatant
was then immunoprecipitated with a specific antibody
against ASK1 or JNK1/2 in the presence of A/G-agarose
beads overnight. The beads were washed three times with
lysis buffer and two times with kinase buffer containing
20 mM HEPES (pH 7.4), 20 mM MgCl2, and 2 mM DTT.
The kinase reactions were performed by incubating
immunoprecipitated beads with 20 l of kinase buffer
supplemented with substrate (50 g/ml myelin basic pro-
tein (MBP) for ASK1 activity or 50 g/ml c-Jun-GST fusion
protein for JNK1/2 activity), 20 M ATP, and 3 Ci of [-
32P] ATP at 30°C for 30 min. The reaction mixtures were
analyzed by 15% SDS-PAGE followed by autoradiogra-
phy.
ROS generation assay
Intracellular ROS formation was measured using the
fluorogenic probe, H2DCFDA (Molecular Probes,
Eugene, OR). Briefly, A549 cells were loaded with 10 M
H2DCFDA for 30 min at 37°C in the dark. After incuba-
tion, cells were treated with 20 M denbinobin for the
indicated time intervals, or pretreated with specific inhib-
itors as indicated followed by denbinobin. Cells then har-
vested, and ROS generation was measured by FACScan
flow cytometry to detect the log of the mean fluorescence
intensity (MFI) with an acquisition of fluorescence chan-
nel 1 (FL1). A minimum number of 10,000 events was
collected and analyzed by the Cellquest program.
Immunoblot analysis
An immunoblot analysis was performed as previously
described [16]. A549 cells were cultured in 6-cm dishes.
After reaching confluence, cells were treated with 20 M
denbinobin for the indicated time intervals, or pretreated
with specific inhibitors, or transiently transfected with
pcDNA, ASK1DN, JNK1DN, or JNK2DN for 6 h followed
by denbinobin. After incubation, cells were washed twice
with ice-cold PBS and solubilized in extraction buffer con-
taining 10 mM Tris (pH 7.0), 140 mM NaCl, 3 mM MgCl2,
2 mM PMSF, 5 mM DTT, 0.5% NP-40, 0.01 mg/ml apro-
tinin, 0.01 mg/ml leupeptin, 1 mM benzamidine, and 1
mM Na3VO4. Protein concentrations of cell lysates were
determined by the Bradford protein assay (Bio-Rad).
Equal amounts of protein (60 g) in each sample were
boiled in SDS sample loading buffer, and then fraction-
ated on SDS-PAGE before being blotted onto a polyvinyli-
dene difluoride (PVDF) membrane. Blots were then
incubated in 150 mM NaCl, 20 mM Tris, and 0.02%
Tween (pH 7.4) containing 5% non-fat milk. Proteins
were visualized by specific primary antibodies and then
incubated with alkaline phosphatase- or horseradish per-
oxidase-conjugated second antibodies. After washing with
PBS, blots were developed using NBT/BCIP or an
enhanced chemiluminescence kit according to the ven-
dor's instructions before exposure to photographic film.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Preparation of nuclear extracts and the electrophoretic 
mobility shift assay (EMSA)
Cells were grown in 6-cm dishes. After reaching conflu-
ence, cells were treated with 20 M denbinobin for the
indicated time intervals. The nuclear protein fractions
were then prepared as described previously [17]. Briefly,
cells were washed with ice-cold PBS, and then centrifuged.
The cell pellet was resuspended in hypotonic buffer (10
mM HEPES, 10 mM KCl, 0.5 mM DTT, 10 mM aprotinin,
10 mM leupeptin, and 20 mM PMSF) for 15 min on ice,
and vortexed for 10 sec. The nuclei were collected by cen-
trifugation at 15,000 × g for 1 min. The pellet containing
nuclei was resuspended in hypertonic buffer (20 mM
HEPES (pH 7.6), 25% glycerol, 1.5 mM MgCl2, 4 mM
EDTA, 0.05 mM DTT, 20 mM PMSF, 10 mM aprotinin,
and 10 mM leupeptin) for 30 min on ice. The superna-
tants containing the nuclear proteins were collected by
centrifugation at 15,000 × g for 30 min and then stored at
-80°C.
A double-stranded oligonucleotide probe containing the
recombinant AP-1 consensus sequence (5'-TTC CGG CTG
ACT CAT CAA GCG-3'; Promega) was end-labeled with [-
32P] ATP using the T4 polynucleotide kinase. The nuclear
extract (2.5~5 g) was incubated with 1 ng of a 32P-
labeled AP-1 probe (50,000~75,000 cpm) in 10 l of
binding buffer containing 1 g poly(dI-dc), 15 mM
HEPES (pH 7.6), 80 mM NaCl, 1 mM EDTA, 1 mM DTT,
and 10% glycerol at 30°C for 25 min. DNA/nuclear pro-
tein complexes were separated from the DNA probe by
electrophoresis on 6% polyacrylamide gels. The gels were
vacuum-dried and subjected to autoradiography with an
intensifying screen at -80°C. For competition experi-
ments, 1 ng of the labeled oligonucleotide was mixed with
50 ng of AP-1 or NF-B unlabeled competitor oligonucle-
otides prior to protein addition. For the supershift experi-
ments, 4 g of the anti-c-Jun or anti-c-Fos antibody was
mixed with the nuclear extract proteins.
Interference of bim expression
To generate siRNAs targeting bim mRNA for degradation,
we produced the pSiREN-bim plasmid to suppress bim
expression. To create pSiREN-bim, artificial complemen-
tary oligonucleotides were annealed and cloned into the
pSIREN-RetroQ-ZsGreen vector (BD Biosciences Clon-
tech, San Diego., CA): the sense oligonucleotide sequence
for bim was 5'-GATCCGTTCTGAGTGTGACCGAGAttcaa-
gagaTCTCGGTCACACTCAGAACTTTTTTG-3'; and the
antisense oligonucleotide sequence for bim  was 3'-
GCAAGACTCACACTGGCTCTaagttctctAGAGCCAGTGT-
GAGTCTTGAAAAAACTTAA-5'. A negative control RNAi
(pSiREN-NC) was also constructed by cloning custom-
synthesized oligonucleotides into the pSIREN-RetroQ-
ZsGreen vector. The accuracies of the pSiREN-bim and pSi-
REN-NC plasmids were confirmed based on the sequenc-
ing analysis.
RNA isolation and semiquantitative (sq)RT-PCR
A549 cells were seeded in 6-cm dishes. After reaching con-
fluence, cells were treated with 20 M denbinobin or 5
mM H2O2 for the indicated time intervals, or pretreated
with specific inhibitors (1 mM NAC, 100 M GSH, or 10
M SP600125) for 30 min, or transiently transfected with
pcDNA, ASK1DN, JNK1DN, or JNK2DN for 6 h followed
by denbinobin. Total RNA was purified using the TRIzol
reagent (Invitrogen) following the manufacturer's proto-
col and quantified by spectrophotometry at a 260 nm
wavelength. RNA was reverse-transcribed, and the cDNA
product was amplified by PCR using 500 ng of specific
forward and reverse primers. -Actin was normalized in
parallel in the same samples. PCR conditions included
pre-incubation at 95°C for 5 min followed by 40 amplifi-
cation cycles (denaturation at 95°C for 1 min, annealing
at 53°C for 1 min, elongation at 72°C for 1 min, and a
final extension for 10 min at 72°C). Forward and reverse
primers for bim were designed for all isoforms except for
bim-: sense, 5'-AAG CAA CCT TCT GAT GTA-3'; anti-
sense, 5'-CAA TGC ATT CTC CAC ACC AG-3'. The sense
primer of -actin was 5'-GAC TAC CTC ATG AAG ATC CT-
3'; and the reverse primer of -actin was 5'-CCA CAT CTG
CTG GAA GGT GG-3'. PCR products were visualized by
UV-illuminated agarose gel electrophoresis.
Statistical analysis
Results are presented as the mean ± SEM from at least
three independent experiments. One-way analysis of vari-
ance (ANOVA), followed by Bonferroni's multiple-range
tests when appropriate, was used to determine the statisti-
cal significance of the difference between the means. A p
value of < 0.05 was considered statistically significant.
Results
ASK1 mediates denbinobin-induced A549 cell apoptosis
ASK1 activation is a pivotal mechanism in a broad range
of cell death paradigms [12]. To explore whether ASK1
activation contributes to denbinobin-induced A549 cell
apoptosis, cells were transiently transfected with the
ASK1DN prior to denbinobin treatment. As shown in Fig.
1A, the percentage of PI-stained cells in the apoptotic
region (Apo, sub-G0/G1 peak, subdiploid peak) was sig-
nificantly increased following 20 M denbinobin treat-
ment, compared to the vehicle-treated group.
Denbinobin-induced A549 cell apoptosis was attenuated
by 48.1 ± 5.2% by transfection with ASK1DN (Fig. 1A). To
further elucidate whether ASK1 activation is involved in
the signaling cascade of denbinobin-induced A549 cell
apoptosis, ASK1 kinase activity was measured after den-
binobin exposure. Treatment of A549 cells with 20 M
denbinobin increased ASK1 kinase activity. This responseJournal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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peaked at 10 min and had returned to the basal level
within 2 h (Fig. 1B). Similarly, 5 mM H2O2, a potent ASK1
stimulator [18], caused an increase in ASK1 kinase activity
in a time-dependent manner (Fig. 1C). These results sug-
gest that ASK1 activation participates in denbinobin-
induced apoptosis in A549 cells.
Involvement of ROS generation in denbinobin-induced 
A549 cell apoptosis
Previous report indicated that ROS play an important role
in apoptotic signaling pathway [19]. To explore the role of
ROS in denbinobin-induced A549 cell apoptosis, the anti-
oxidants, NAC and GSH, were used. As shown in Fig. 2A,
pretreatment of A549 cells with 1 mM NAC and 100 M
GSH markedly attenuated denbinobin-induced A549 cell
apoptosis by 95.4 ± 2.8% and 77.0 ± 4.1%, respectively.
Moreover, treatment of cells with 20 M denbinobin
caused a time-dependent increase in ROS production with
a maximum effect at 5~10 min after denbinobin treat-
ment. However, after 60 min of treatment with den-
binobin, the response had decreased (Fig. 2B).
Furthermore, denbinobin-induced ROS formation was
almost completely inhibited by treatment with 1 mM
NAC or 100 M GSH (Fig. 2C). These results suggest that
denbinobin caused intracellular ROS generation, and the
oxidative stress further contributed to A549 cell apoptosis.
Previous studies showed that ROS might activate ASK1
through oxidizing thioredoxin (Trx) and glutaredoxin
[20-22]. We next speculated whether ROS generation
results in ASK1 activation in denbinobin-mediated apop-
tosis. As illustrated in Fig. 2D, the denbinobin-induced
increase in ASK1 activity was markedly inhibited by 1 mM
Figure 1
ASK1 activation is involved in denbinobin-induced apoptosis  in A549 cells Figure 1
ASK1 activation is involved in denbinobin-induced 
apoptosis in A549 cells. (A) A549 cells were transiently 
transfected with pcDNA (mock) or ASK1DN for 6 h. Fol-
lowing transfection, cells were replaced with fresh culture 
medium for 24 h and treated with vehicle or 20 M den-
binobin for another 24 h. The percentage of apoptotic cells 
was then determined using flow cytometric analysis of PI-
stained cells as described in "Materials and methods". Each 
column represents the mean ± S.E.M. of at least three inde-
pendent experiments. *p < 0.05, compared to the mock 
transfection group in the presence of denbinobin. Cells were 
treated with 20 M denbinobin (B) or 5 mM H2O2 (C) for 
the indicated time intervals. Cell lysates were then immuno-
precipitated with the anti-ASK1 antibody, and the kinase 
activity was measured as described in "Materials and meth-
ods". Equal loading in each lane is reflected by similar intensi-
ties of -tubulin. Compiled results are shown in the lower 
panel. Each column represents the mean ± S.E.M. of at least 
three independent experiments. * p < 0.05, compared to the 
control group without denbinobin or H2O2 treatment.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Figure 2
ROS generation mediates denbinobin-induced apoptosis in A549 cells. (A) Following pretreatment with NAC (1
mM) or GSH (100 M) for 30 min, cells were incubated with the vehicle or 20 M denbinobin for another 24 h. Cells then
were harvested, and apoptosis was analyzed by flow cytometry as described in "Materials and methods". Each column repre-
sents the mean ± S.E.M. of at least three independent experiments performed in triplicate. * p < 0.05, compared to the group
treated with denbinobin. (B) Cells were treated with 20 M denbinobin, and DCF fluorescence was monitored by flow cytom-
etry for up to 120 min as described in "Materials and methods". Results are plotted as the mean fluorescence intensity (MFI) ±
S.E.M. of five independent experiments. * p < 0.05, compared to the control group. (C) Cells were pretreated with NAC (1
mM) or GSH (100 M) for 30 min prior to denbinobin (20 M) stimulation for 10 min. ROS generation was detected by
H2DCFDA using flow cytometry. Data are represented as the MFI ± S.E.M. of three independent experiments. * p < 0.05,
compared to the group treated with denbinobin. (D) Cells were pretreated with NAC (1 mM) or GSH (100 M) for 30 min
before treatment with 20 M denbinobin for another 10 min. ASK1 kinase activity was then measured. Equal loading in each
lane is reflected by similar intensities of -tubulin. Compiled results are shown in the lower panel. Each column represents the
mean ± S.E.M. of at least three independent experiments. * p < 0.05, compared to the control group in the presence of den-
binobin. Cells were transiently transfected with pcDNA (mock), AktDN (E) or ASK1DN (F) for 6 h. Following transfection,
cells were replaced with fresh culture medium for 24 h and treated with vehicle or 20 M denbinobin for another 10 min (for
ASK1 kinase activity) or 6 h (for Akt phosphorylation). Cell lysates were then prepared and subjected to ASK1 kinase activity
or Akt phosphorylation as described in "Materials and methods". Equal loading in each lane is demonstrated by similar intensi-
ties of -tubulin or Akt1/2, respectively. Compiled results are shown in the lower panel. Typical traces are representative of
two experiments with similar results.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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NAC and 100 M GSH by 79.5 ± 15.1% and 80.1 ± 9.6%,
respectively. Our previous study has shown that den-
binobin-induced A549 cell apoptosis involving Akt inac-
tivation [6]. Next, we investigated whether Akt is involved
in denbinobin-induced ASK1 activity. When A549 cells
transfected with 1 g AktDN did not affect denbinobin-
induced ASK1 activity (Fig. 2E). Furthermore, we exam-
ined whether ASK1 is involved in denbinobin-induced
Akt inactivation. As shown in Fig. 2F, transfection of A549
cells with 1 g ASK1DN did not affect denbinobin-
induced Akt Ser473 dephosphorylation. These results sug-
gest that denbinobin-induced Akt inactivation and ASK1
activation are through two independent signal pathways.
JNK is involved in denbinobin-induced A549 cell apoptosis
ASK1 belongs to the MAPKKK family and activates the
JNK and p38MAPK pathways via MKK4/7 and MKK3/6,
respectively [11]. In the present study, we focused on the
role of the JNK signaling cascade in denbinobin-induced
A549 cell apoptosis. We examined whether JNK signaling
events are involved in denbinobin-induced A549 cell
apoptosis. The specific JNK inhibitor, SP600125 (10 M),
markedly attenuated denbinobin-induced A549 cell
apoptosis by 56.0 ± 12.3% (Fig. 3A). We next examined
whether denbinobin was able to activate JNK1/2. Results
from Fig. 3B illustrate that 20 M denbinobin time-
dependently increased JNK1/2 phosphorylation, with a
maximum effect at 30 min of denbinobin exposure. The
protein level of JNK1/2 was not affected by the presence
of denbinobin (Fig. 3B, bottom panel). In parallel, using
the c-Jun-GST fusion protein as the JNK1/2 substrate, a
time-dependent increase in JNK1/2 activity was also
observed in denbinobin-treated A549 cells (Fig. 3C). To
determine the relationships among ROS, ASK1, and JNK
in the denbinobin-mediated signaling pathway, we deter-
mined the effects of two antioxidants (NAC and GSH) and
ASK1DN on denbinobin-induced JNK activation. As
shown in Fig. 4A, pretreatment of A549 cells for 30 min
with 1 mM NAC and 100 M GSH markedly inhibited
denbinobin-induced JNK1/2 activation. Neither of these
treatments had any effect on the protein level of JNK1/2
(Fig. 4A, bottom panel). Furthermore, transfection of
A549 cells with ASK1DN significantly reduced den-
binobin-induced JNK1/2 activation by 50.1 ± 11.7% (Fig.
4B). However, ASK1DN did not affect the protein level of
JNK1/2 (Fig. 4B, bottom panel). Taken together, these
findings suggest that the ROS-ASK1 cascade is required for
denbinobin-induced JNK1/2 activation in A549 cells.
AP-1 is involved in denbinobin-induced A549 cell apoptosis
We next wished to determine whether AP-1 is involved in
denbinobin-induced cell apoptosis by using the AP-1
inhibitor curcumin. As shown in Fig. 5A, denbinobin-
induced cell apoptosis was attenuated by pretreatment of
cells with 1 M curcumin by 21 ± 5% (n = 3). Moreover,
1 M curcumin inhibited the decrease of cell viability after
exposure to 20 M denbinobin by 42 ± 10% by MTT test
(data not shown). The transcription factor, AP-1, is com-
posed of heterodimeric protein complexes comprising a
protein family group such as c-Jun and c-Fos. Activation of
c-Jun requires a phosphorylation process manipulated by
activated JNK [23]. Therefore, we measured c-Jun phos-
phorylation after denbinobin treatment. Treatment of
A549 cells with 20 M denbinobin caused a time-depend-
ent increase in c-Jun phosphorylation. This response
reached a maximum at 30 min and had declined after 120
min treatment with denbinobin (Fig. 5B). The protein
level of c-Jun was not affected by the presence of den-
binobin (Fig. 5B, bottom panel). The nuclear extracts of
A549 cells with or without denbinobin treatment were
subjected to EMSA using AP-1-specific oligonucleotides as
the probes. As shown in Fig. 5C, AP-1-specific DNA-pro-
tein complex formation time-dependently increased with
a maximum effect at 30 min of denbinobin treatment.
However, after 120 min of treatment with denbinobin,
the intensities of these DNA-protein complexes had
decreased (Fig. 5C). Formation of the DNA-protein com-
plex was completely reduced by the addition of 50× cold
AP-1 consensus DNA oligonucleotides. However, 50×
cold NF-B consensus DNA oligonucleotides did not
affect AP-1-specific DNA-protein complex formation (Fig.
5C). These results indicated that the DNA-protein interac-
tions were AP-1 sequence specific. To identify the specific
subunits involved in the formation of the AP-1 complex
after denbinobin stimulation, EMSA was also performed
in the presence of specific antibodies against c-Jun or c-
Fos. As shown in Fig. 5C, pretreatment of nuclear extracts
with a specific antibody against either c-Jun or c-Fos
reduced the AP-1-specific DNA-protein binding activity,
demonstrating that the components of the AP-1 het-
erodimer are c-Jun and c-Fos. Furthermore, we deter-
mined whether ROS, ASK1, and JNK mediated
denbinobin-induced c-Jun activation. As shown in Fig. 6,
denbinobin-induced c-Jun phosphorylation was mark-
edly attenuated in cells pretreated for 30 min with 1 mM
NAC, 100 M GSH, and 10 M SP600125 by 99.9 ± 3.9%,
81.6 ± 5.6%, and 59.9 ± 7.8%, respectively (Fig. 6A, B).
Moreover, transfection of A549 cells with ASK1DN,
JNK1DN, and JNK2DN all inhibited denbinobin-induced
c-Jun phosphorylation (Fig. 6C). Based on these results,
we suggest that the ROS-ASK1-JNK1/2 cascade occurs
upstream of c-Jun phosphorylation in the denbinobin-
induced signaling pathway.
Bim upregulation is involved in denbinobin-induced 
apoptosis
To investigate whether silencing Bim interrupts den-
binobin-induced A549 cell apoptosis, cells were tran-
siently transfected with Bim-specific siRNA (pSiREN-bim)
following DNA content analysis by flow cytometry. AsJournal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Involvement of JNK activation in denbinobin-induced apoptosis in A549 cells Figure 3
Involvement of JNK activation in denbinobin-induced apoptosis in A549 cells. (A) Cells were pretreated with 
SP600125 (10 M) for 30 min before incubation with 20 M denbinobin for 24 h, and then apoptosis was detected using flow 
cytometry of PI-stained cells as described in "Materials and methods". Each column represents the mean ± SEM of at least 
three independent experiments. *p < 0.05, compared to the denbinobin group. Cells were treated with 20 M denbinobin for 
the indicated time intervals. Cell lysates were then prepared and subjected to JNK phosphorylation (B) or JNK kinase activity 
(C) as described in "Materials and methods". Equal loading in each lane is demonstrated by similar intensities of JNK. Compiled 
results are shown in the lower panel. Each column represents the mean ± S.E.M. of at least three independent experiments. * 
p < 0.05, compared to the control group.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Involvement of ROS and ASK1 in denbinobin-induced JNK activation in A549 cells Figure 4
Involvement of ROS and ASK1 in denbinobin-induced JNK activation in A549 cells. Cells were pretreated with 1 
mM NAC or 100 M GSH (A) or transiently transfected with pcDNA or ASK1DN for 6 h (B) before incubation with 20 M 
denbinobin for 30 min. Cells were then harvested and subjected to immunoblotting for JNK phosphorylation as described in 
"Materials and methods". Equal loading in each lane is shown by the similar intensities of JNK. Compiled results are shown in 
the lower panel. Each column represents the mean ± S.E.M. of at least three independent experiments. * p < 0.05, compared to 
the denbinobin group.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Figure 5
Involvement of AP-1 activation in denbinobin-induced apoptosis in A549 cells. (A) Cells were pretreated with cur-
cumin (1 M) for 30 min before incubation with 20 M denbinobin for another 24 h, and then apoptosis was detected using 
flow cytometry of PI-stained cells as described in "Materials and methods". Each column represents the mean ± SEM of at least 
three independent experiments. *p < 0.05, compared to the denbinobin group. (B) Cells were treated with 20 M denbinobin 
for 10, 30, 60, and 120 min. Cells were then harvested and subjected to immunoblotting with an anti-phospho-c-Jun antibody 
as described in "Materials and methods". Equal loading in each lane is shown by the similar intensities of c-Jun. Compiled results 
are shown in the lower panel. Each column represents the mean ± S.E.M. of at least three independent experiments. * p < 0.05, 
compared to the control group. (C) Cells were incubated with 20 M denbinobin for various time intervals. Following incuba-
tion, the nuclear protein fraction was prepared, and AP-1-specific DNA protein complex formation was analyzed by an EMSA 
as described in "Materials and methods". The antibodies of c-Jun and c-Fos were incubated prior to detecting the specificity of 
AP-1 binding activity. Fifty-fold concentrations of unlabeled AP-1 or NF-B oligonucleotides (50× cold) were used for the com-
petition experiment. Data shown are representative of three independent experiments with similar results.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Involvement of ROS, ASK1, and JNK in denbinobin-induced c-Jun phosphorylation in A549 cells Figure 6
Involvement of ROS, ASK1, and JNK in denbinobin-induced c-Jun phosphorylation in A549 cells. Cells were pre-
treated with 1 mM NAC, 100 M GSH (A), or 10 M SP600125 (B), or transiently transfected with pcDNA, ASK1DN, 
JNK1DN, or JNK2DN for 6 h (C). After treatment, cells were treated with vehicle or 20 M denbinobin for 30 min. Cells 
were then harvested for immunoblotting to assess the level of c-Jun phosphorylation as described in "Materials and methods". 
Equal loading in each lane is reflected by approximately similar intensities of the c-Jun bands. Compiled results are shown in the 
lower panel. Each column represents the mean ± S.E.M. of at least three independent experiments. * p < 0.05, compared to the 
denbinobin group. * p < 0.05, compared to the control group (A and B) or the pcDNA (mock) group (C) in the presence of 
denbinobin.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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shown in Fig 7A, cells receiving pSiREN-bim displayed a
reduced proportion of denbinobin-induced cell apoptosis
by 44.5 ± 12.9%, suggesting that Bim upregulation medi-
ates A549 cell apoptosis induced by denbinobin. Next, we
examined whether denbinobin treatment increased
expression of Bim mRNA determined by sqRT-PCR. As
shown in Fig. 7B, exposure of A549 cells to 20 M den-
binobin resulted in Bim mRNA expression. A maximal
response was reached after 2~4 h of treatment, and had
decreased to the basal level after 6 h of treatment. Simi-
larly, 5 mM H2O2 induced Bim mRNA expression in a
time-dependent manner (Fig. 7C). Furthermore, pretreat-
ment of A549 cells with 1 mM NAC, 100 M GSH, and 10
M SP600125 all inhibited denbinobin-mediated Bim
mRNA expression (Fig. 7D). Moreover, denbinobin-
induced Bim mRNA expression was also markedly inhib-
ited by transfection with ASK1DN, JNK1DN, and
JNK2DN (Fig. 7E). These results suggest that the ROS-
ASK1-JNK cascade is required for denbinobin-induced
Bim expression in A549 cells.
Discussion
Our previous study showed that Akt inactivation, fol-
lowed by Bad activation, mitochondrial dysfunction, cas-
pase 3 activation, and AIF release, contributes to
denbinobin-induced apoptosis in human lung adenocar-
cinoma (A549) cells. However, the precise molecular
mechanism responsible for the apoptotic action of den-
binobin remains to be fully characterized. The findings of
this study demonstrated that activation of the ROS-ASK1-
JNK signaling cascade followed by AP-1 activation and
Bim expression contributes to denbinobin-induced apop-
tosis in A549 cells.
Activated ASK1 plays a critical role in regulating diverse
physiological processes, including cell differentiation and
apoptosis, by stimulating downstream signaling events
including activation of MKK4/7 and JNK in sequence
[24,25]. JNK is thought to play a role in AP-1-mediated
transcriptional activation of the target genes [26,27].
However, whether the ASK1-JNK-AP-1 signaling pathway
participates in denbinobin-induced A549 cell apoptosis
has not been demonstrated. In this study, we found that
treatment of A549 cells with denbinobin caused sequen-
tial activations of ASK1, JNK, c-Jun, and AP-1, and that the
dominant-negative mutants of ASK1, JNK1, and JNK2,
and the inhibitors of JNK and AP-1 attenuated den-
binobin-induced cell apoptosis in A549 cells. The domi-
nant-negative mutant of ASK1 suppressed denbinobin-
induced JNK1/2 activation. Moreover, denbinobin-
induced c-Jun phosphorylation was inhibited by the dom-
inant-negative mutants of ASK1, JNK1, and JNK2, and the
JNK inhibitor. These results suggest that denbinobin
might activate ASK1, causing JNK and c-Jun activation,
which in turn induces AP-1 activation, and ultimately
leads to A549 cell apoptosis.
ASK1 activity is regulated by interactions with various pro-
teins. When free of oxidative stress, the inactive form of
ASK1 is phosphorylated at the serine at residue 967 and is
suppressed by interactions with its repressors, such as
thioredoxin (Trx), glutaredoxin (Grx), and the 14-3-3 pro-
tein. Previous studies showed that ROS might activate
ASK1 through oxidizing thioredoxin (Trx) and glutare-
doxin [20-22]. Recent reports also indicated that ASK1 is
response to oxidative stress such as H2O2 through decreas-
ing phosphorylation at serine 967 parallel to increasing
the dissociation with inhibitory proteins leading to activa-
tion of the apoptotic function [20,28]. In this study, we
found that denbinobin induced ROS formation, and that
two antioxidants (NAC and GSH) inhibited denbinobin-
induced ASK1 activation, JNK activation, c-Jun phosphor-
ylation, and cell apoptosis. In addition, treatment of A549
cells with H2O2 induced ASK1 activation. These findings
suggest that ROS may play a pivotal role in denbinobin-
induced ASK1 activation and subsequent signaling events.
Bcl-2 family proteins regulate mitochondria-dependent
apoptosis with the balance of the anti- and proapoptotic
members arbitrating life-or-death decisions. Bim, a proa-
poptotic member of the Bcl-2 family, causes apoptosis by
disrupting mitochondrial integrity. bim gene expression is
induced by AP-1 in response to selected stress signals
[29,30]. In the present study, we found that denbinobin
induced Bim expression and that Bim siRNA attenuated
denbinobin-induced A549 cell apoptosis, suggesting that
Bim expression is causally related to denbinobin-induced
A549 cell apoptosis. Furthermore, denbinobin-induced
Bim expression was inhibited by antioxidants, a JNK
inhibitor, and the dominant-negative mutants of ASK1,
JNK1, and JNK2. Similarly, treatment of cells with H2O2
induced ASK1 activation. Thus, it is plausible that den-
binobin activates the ROS-ASK1-JNK cascade causing Bim
expression and subsequent cell apoptosis. Recent reports
have indicated that in addition to Bim, BH3-only mem-
bers of the Bcl-2 family, such as Bad, also participate in
denbinobin-induced A549 cell apoptosis [6]. These obser-
vations explain, at least in part, why blocking the ASK1
signaling cascade did not completely abolish denbinobin-
induced A549 cell apoptosis.
Conclusion
In conclusion, results from the present study demonstrate
for the first time that denbinobin-induced A549 cell apop-
tosis is involved at least in part with activation of the ROS-
ASK1-JNK-c-Jun signaling cascade to induce AP-1 activa-
tion and Bim expression. The present study, together with
our previous report delineates, in part, the signaling path-
ways involved in denbinobin-induced A549 cell apopto-Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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Bim expression is involved in denbinobin-induced apoptosis in A549 cells Figure 7
Bim expression is involved in denbinobin-induced apoptosis in A549 cells. (A) Following transfection with control 
siRNA or bim siRNA for 6 h, cells were treated with vehicle or 20 M denbinobin for another 24 h. The DNA content was 
then analyzed by flow cytometry of PI-stained cells as described in "Materials and methods". Each column represents the mean 
± S.E.M. of at least three independent experiments. * p < 0.05, compared to the control siRNA group in the presence of den-
binobin. Cells were incubated with 20 M denbinobin (B) or 5 mM H2O2 (C) for the indicated intervals, pretreated with 1 mM 
NAC, 100 M GSH, or 10 M SP600125 (D), or transiently transfected with pcDNA, ASK1DN, JNK1DN, or JNK2DN for 6 h 
(E). Cells were then treated with vehicle or 20 M denbinobin for 2 h. Following treatment, RNA was collected to assess bim 
expression by semiquantitative RT-PCR as described in "Materials and methods". Samples were normalized for -actin intensi-
ties. Typical traces are representative of three experiments with similar results.Journal of Biomedical Science 2009, 16:43 http://www.jbiomedsci.com/content/16/1/43
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sis. Figure 8 is a schematic representation of the signaling
pathway of denbinobin-induced cell apoptosis in human
lung adenocarcinoma cells. Thus, denbinobin may be use-
ful as a potential template for the development of better
chemopreventive and/or chemotherapeutic agents.
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